Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Mor

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Heat shock protein 60 activates B cells via the TLR4-MyD88 pathwayMichal Cohen-Sfady, Gabriel Nussbaum, Meirav Pevsner-Fischer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 2011
Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cellsIlan Volovitz, Yotvat Marmor, Meir Azulay, et al.
Stem Cell Reviews and Reports|September 2, 2011
Stable changes in mesenchymal stromal cells from multiple myeloma patients revealed through their responses to Toll-like receptor ligands and epidermal growth factorMeirav Pevsner-Fischer, Sarit Levin, Tal Hammer-Topaz, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Heat shock protein 60 activates B cells via the TLR4-MyD88 pathwayMichal Cohen-Sfady, Gabriel Nussbaum, Meirav Pevsner-Fischer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 2011
Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cellsIlan Volovitz, Yotvat Marmor, Meir Azulay, et al.
Stem Cell Reviews and Reports|September 2, 2011
Stable changes in mesenchymal stromal cells from multiple myeloma patients revealed through their responses to Toll-like receptor ligands and epidermal growth factorMeirav Pevsner-Fischer, Sarit Levin, Tal Hammer-Topaz, et al.
Pageof 3